Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity ...

Some 25 years ago, a young Parkinson's disease investigator, Robert Hauser, MD, stepped to the podium at an American Academy ...

The American Academy of Neurology (AAN) has issued a position statement on therapies for neurological conditions that have ...

The FDA’s regular communications based on reports from its drug safety report database don’t always rattle investors’ cages. | In a quarterly update, the FDA said it’s evaluating the need for ...

An autopsy study of a 45-year-old former U.S. Navy crewman with severe chronic traumatic encephalopathy (CTE) suggested that ...

The American Academy of Neurology issues new guidelines to help clinicians navigate the use of unproven neurologic therapies lacking FDA approval or strong evidence.

Living in disadvantaged neighborhoods may increase the risk of Alzheimer’s disease by elevating biomarkers associated with inflammation and neurodegeneration.

People living in more disadvantaged neighborhoods may be more likely to have biomarkers for inflammation and Alzheimer's ...

Recurrent headaches are the number-one cause of disability of people under age 50, but remain under-diagnosed.

Presented at: American Academy of Neurology Annual Meeting; April 5-9, 2025; San Diego. Their population-based study examined records of individuals from the Arizona Health Care Cost Containment ...